Market Tracker

05/24 5:16pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

117.80
Delayed Data
As of 3:59pm ET
 +1.21 / +1.04%
Today’s Change
71.46
Today|||52-Week Range
121.96
+59.90%
Year-to-Date

Today’s Trading

Previous close116.59
Today’s open116.86
Day’s range115.10 - 118.44
Volume1,818,349
Average volume (3 months)1,810,684
Market cap$29.0B
Dividend yield--
Data as of 3:59pm ET, 05/24/2017

Growth & Valuation

Earnings growth (last year)+80.09%
Earnings growth (this year)+92.71%
Earnings growth (next 5 years)+68.90%
Revenue growth (last year)+64.89%
P/E ratio168.3
Price/Sales10.59
Price/Book25.03

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.87+1.42%
BAXBaxter International...+0.42+0.73%
INCYIncyte Corp+1.94+1.42%
ALXNAlexion Pharmaceutic...-3.56-3.40%
Data as of 4:01pm ET, 05/24/2017

Financials

Next reporting dateJuly 31, 2017
EPS forecast (this quarter)$0.36
Annual revenue (last year)$1.7B
Annual profit (last year)-$112.1M
Net profit margin-6.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
EVP, Chief Operating &
Financial Officer
Ian F. Smith
Corporate headquarters
Boston, Massachusetts

Forecasts